Gilead Sciences has reached a $202 million settlement to resolve a civil fraud lawsuit accusing the company of paying kickbacks to doctors who agreed to prescribe its HIV drugs, the U.S. attorney's ...

Gilead Sciences to Pay $202 Million in US Settlement Over HIV Drug Kickbacks By Jonathan Stempel NEW YORK (Reuters) -Gilead Sciences agreed to pay $202 million to settle a whistleblower lawsuit ...

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement comes a month after a federal judge in New Jersey ruled that ...

Now, Gilead Sciences has agreed to fork over $202 million ... according to the government. As part of the settlement, Gilead admitted to certain conduct, such as paying one speaker more than ...

Gilead Sciences agreed to pay $202 million to the ... prescribe Gilead's HIV drugs and drive up sales," Clayton said. The settlement, which calls for Gilead to pay the U.S. nearly $177 million ...

A patent dispute between ViiV Healthcare and Gilead Sciences has been resolved, with Gilead agreeing to pay a $1.25 billion settlement as well as royalties on sales of one of its top HIV products.

Gilead Sciences announced positive data regarding ... Over the three-year period ending April 2025, Gilead's total shareholder return reached 78.08%, presenting a stark contrast to more recent ...

NEW YORK, April 29 (Reuters) - Gilead Sciences (GILD.O), opens new tab ... to doctors who agreed to prescribe its HIV drugs. The settlement announced on Tuesday by U.S. Attorney Jay Clayton ...

The U.S. Attorney's Office joined Bellman's lawsuit against Gilead. The settlement, which calls for Gilead to pay the U.S. nearly $177 million and the balance to various states, was approved ...